How much debt does Crinetics Pharmaceuticals have?

According to Crinetics Pharmaceuticals's latest annual financial reports, the company's debt profile is as follows:

Total Debt and Liabilities

Crinetics Pharmaceuticals's total debt stands at $51.72M. This is broken down into:

• Long-term debt: $44.57M
• Short-term debt: $7.15M

The company's net debt, which accounts for cash and cash equivalents, is $-212.82M. In terms of overall financial obligations, Crinetics Pharmaceuticals's total liabilities amount to $109.79M.

Debt Ratios and Metrics

To better understand Crinetics Pharmaceuticals's debt position, we can look at several key ratios:

• Debt to Equity Ratio: 0.04 - this indicates the proportion of equity and debt the company uses to finance its assets.
• Debt Ratio: 3.61% - this shows the proportion of a company's assets that are financed through debt.
• Interest Coverage Ratio: 0.00 - this measures how easily a company can pay interest on its outstanding debt.
• Long-term Debt to Capitalization: 3.25% - this shows the proportion of long-term debt in the company's capital structure.
• Total Debt to Capitalization: 3.76% - this indicates the total debt in the company's capital structure.

These metrics provide insight into Crinetics Pharmaceuticals's financial leverage and its ability to meet financial obligations. For a comprehensive understanding of the company's financial health, it's important to consider these debt metrics alongside other financial indicators and industry benchmarks.